vs

Side-by-side financial comparison of Credo Technology Group Holding Ltd (CRDO) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Credo Technology Group Holding Ltd is the larger business by last-quarter revenue ($268.0M vs $142.0M, roughly 1.9× Oncology Institute, Inc.). Credo Technology Group Holding Ltd runs the higher net margin — 30.8% vs -5.3%, a 36.1% gap on every dollar of revenue. On growth, Credo Technology Group Holding Ltd posted the faster year-over-year revenue change (272.1% vs 41.6%). Credo Technology Group Holding Ltd produced more free cash flow last quarter ($38.5M vs $2.2M). Over the past eight quarters, Credo Technology Group Holding Ltd's revenue compounded faster (124.8% CAGR vs 22.5%).

Seiko Group is a corporate group composed of Seiko Group Corporation and its subsidiaries and affiliates. It used to be recognized as a corporate group consisting of three core companies Seiko Holdings Corp., Seiko Instruments Inc., and Seiko Epson Corp. The three companies were linked by a common thread of timepiece technology. Although Epson still develops and manufactures wristwatches for the Seiko Group, Epson and its subsidiaries are not considered part of the group.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

CRDO vs TOI — Head-to-Head

Bigger by revenue
CRDO
CRDO
1.9× larger
CRDO
$268.0M
$142.0M
TOI
Growing faster (revenue YoY)
CRDO
CRDO
+230.5% gap
CRDO
272.1%
41.6%
TOI
Higher net margin
CRDO
CRDO
36.1% more per $
CRDO
30.8%
-5.3%
TOI
More free cash flow
CRDO
CRDO
$36.3M more FCF
CRDO
$38.5M
$2.2M
TOI
Faster 2-yr revenue CAGR
CRDO
CRDO
Annualised
CRDO
124.8%
22.5%
TOI

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
CRDO
CRDO
TOI
TOI
Revenue
$268.0M
$142.0M
Net Profit
$82.6M
$-7.5M
Gross Margin
67.5%
Operating Margin
29.4%
-4.9%
Net Margin
30.8%
-5.3%
Revenue YoY
272.1%
41.6%
Net Profit YoY
2055.9%
43.0%
EPS (diluted)
$0.44
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRDO
CRDO
TOI
TOI
Q4 25
$268.0M
$142.0M
Q3 25
$223.1M
$136.6M
Q2 25
$170.0M
$119.8M
Q1 25
$135.0M
$104.4M
Q4 24
$72.0M
$100.3M
Q3 24
$59.7M
$99.9M
Q2 24
$60.8M
$98.6M
Q1 24
$53.1M
$94.7M
Net Profit
CRDO
CRDO
TOI
TOI
Q4 25
$82.6M
$-7.5M
Q3 25
$63.4M
$-16.5M
Q2 25
$36.6M
$-17.0M
Q1 25
$29.4M
$-19.6M
Q4 24
$-4.2M
$-13.2M
Q3 24
$-9.5M
$-16.1M
Q2 24
$-10.5M
$-15.5M
Q1 24
$428.0K
$-19.9M
Gross Margin
CRDO
CRDO
TOI
TOI
Q4 25
67.5%
Q3 25
67.4%
Q2 25
67.2%
Q1 25
63.6%
Q4 24
63.2%
Q3 24
62.4%
Q2 24
65.8%
Q1 24
61.4%
Operating Margin
CRDO
CRDO
TOI
TOI
Q4 25
29.4%
-4.9%
Q3 25
27.2%
-5.9%
Q2 25
19.9%
-9.4%
Q1 25
19.4%
-9.5%
Q4 24
-11.7%
-11.9%
Q3 24
-24.2%
-13.9%
Q2 24
-13.0%
-16.6%
Q1 24
-11.1%
-19.0%
Net Margin
CRDO
CRDO
TOI
TOI
Q4 25
30.8%
-5.3%
Q3 25
28.4%
-12.1%
Q2 25
21.5%
-14.2%
Q1 25
21.7%
-18.8%
Q4 24
-5.9%
-13.1%
Q3 24
-16.0%
-16.1%
Q2 24
-17.2%
-15.7%
Q1 24
0.8%
-21.0%
EPS (diluted)
CRDO
CRDO
TOI
TOI
Q4 25
$0.44
$-0.04
Q3 25
$0.34
$-0.14
Q2 25
$0.22
$-0.15
Q1 25
$0.16
$-0.21
Q4 24
$-0.03
$-0.14
Q3 24
$-0.06
$-0.18
Q2 24
$-0.06
$-0.17
Q1 24
$0.00
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRDO
CRDO
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$813.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$-15.7M
Total Assets
$1.4B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRDO
CRDO
TOI
TOI
Q4 25
$813.6M
Q3 25
$479.6M
Q2 25
$431.3M
Q1 25
$379.2M
Q4 24
$383.0M
Q3 24
$398.6M
Q2 24
$410.0M
$9.9M
Q1 24
$409.1M
$29.8M
Stockholders' Equity
CRDO
CRDO
TOI
TOI
Q4 25
$1.3B
$-15.7M
Q3 25
$781.4M
$-12.3M
Q2 25
$681.6M
$-9.0M
Q1 25
$618.2M
$5.1M
Q4 24
$567.9M
$3.6M
Q3 24
$553.1M
$15.5M
Q2 24
$540.2M
$29.2M
Q1 24
$534.0M
$41.3M
Total Assets
CRDO
CRDO
TOI
TOI
Q4 25
$1.4B
$164.7M
Q3 25
$905.2M
$163.6M
Q2 25
$809.3M
$159.8M
Q1 25
$719.9M
$164.0M
Q4 24
$638.6M
$172.7M
Q3 24
$644.9M
$179.2M
Q2 24
$601.9M
$179.6M
Q1 24
$592.5M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRDO
CRDO
TOI
TOI
Operating Cash FlowLast quarter
$61.7M
$3.2M
Free Cash FlowOCF − Capex
$38.5M
$2.2M
FCF MarginFCF / Revenue
14.4%
1.5%
Capex IntensityCapex / Revenue
8.7%
0.7%
Cash ConversionOCF / Net Profit
0.75×
TTM Free Cash FlowTrailing 4 quarters
$143.6M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRDO
CRDO
TOI
TOI
Q4 25
$61.7M
$3.2M
Q3 25
$54.2M
$-12.6M
Q2 25
$57.8M
$-10.2M
Q1 25
$4.2M
$-5.0M
Q4 24
$10.3M
$4.2M
Q3 24
$-7.2M
$819.0K
Q2 24
$4.2M
$-15.7M
Q1 24
$-1.0M
$-15.9M
Free Cash Flow
CRDO
CRDO
TOI
TOI
Q4 25
$38.5M
$2.2M
Q3 25
$51.3M
$-13.2M
Q2 25
$54.2M
$-11.4M
Q1 25
$-383.0K
$-5.3M
Q4 24
$-11.7M
$2.4M
Q3 24
$-13.1M
$417.0K
Q2 24
$962.0K
$-17.5M
Q1 24
$-6.1M
$-16.5M
FCF Margin
CRDO
CRDO
TOI
TOI
Q4 25
14.4%
1.5%
Q3 25
23.0%
-9.7%
Q2 25
31.9%
-9.5%
Q1 25
-0.3%
-5.1%
Q4 24
-16.2%
2.4%
Q3 24
-21.9%
0.4%
Q2 24
1.6%
-17.7%
Q1 24
-11.6%
-17.4%
Capex Intensity
CRDO
CRDO
TOI
TOI
Q4 25
8.7%
0.7%
Q3 25
1.3%
0.4%
Q2 25
2.1%
1.0%
Q1 25
3.4%
0.3%
Q4 24
30.5%
1.8%
Q3 24
9.8%
0.4%
Q2 24
5.3%
1.9%
Q1 24
9.6%
0.6%
Cash Conversion
CRDO
CRDO
TOI
TOI
Q4 25
0.75×
Q3 25
0.85×
Q2 25
1.58×
Q1 25
0.14×
Q4 24
Q3 24
Q2 24
Q1 24
-2.42×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRDO
CRDO

Other$132.1M49%
HK$104.4M39%
RESTOFTHEWORLD$31.5M12%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons